January 25, 2020

January 24, 2020

Subscribe to Latest Legal News and Analysis

January 23, 2020

Subscribe to Latest Legal News and Analysis

January 22, 2020

Subscribe to Latest Legal News and Analysis

DOE Accepting Applicants For SBIR/STTR FY 2020 Phase I Release 2 Application Assistance

On December 6, 2019, DOE announced that the applications currently being accepted for free assistance preparing Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) FY 2020 Phase I Release 2 applications. There are a variety of eligibility criteria, and because space is limited, DOE Phase 0 applicants are admitted on a first-come, first-served basis. Each small business, however, is evaluated for selection to receive administrative and technical assistance based on the following selection criteria:

  • The small business offers technology innovations relevant to the current and open DOE SBIR/STTR research topics and subtopics (topics can be accessed at science.osti.gov/sbir);

  • The small business is or will be prior to award an eligible small business per 13 CFR Section 121.702;

  • The small business has not previously applied for an SBIR or STTR award from the DOE; and

  • Small business and/or owner has not received any Phase 0 technical assistance from DOE.

Qualified small businesses can submit an application at www.dawnbreaker.com/doephase0/apply.php.

 
©2020 Bergeson & Campbell, P.C.

TRENDING LEGAL ANALYSIS


About this Author

Lynn Bergeson, Campbell PC, Toxic Substances Control Act Attorney, federal insecticide lawyer, industrial biotechnology legal counsel, Food Drug Administration law
Managing Partner

Lynn L. Bergeson has earned an international reputation for her deep and expansive understanding of the Toxic Substances Control Act (TSCA), the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA), European Union Registration, Evaluation, Authorization and Restriction of Chemicals (REACH), and especially how these regulatory programs pertain to nanotechnology, industrial biotechnology, synthetic biology, and other emerging transformative technologies. Her knowledge of and involvement in the policy process allows her to develop client-focused strategies whether...

202-557-3801